Medical Xpress August 22, 2024
A wildly popular class of drugs called GLP-1 agonists—which includes Ozempic, Wegovy, Mounjaro, and Zepbound—are revolutionizing the treatment of obesity.
One in eight adults has tried a GLP-1 drug for weight loss or to manage their diabetes, and a tidal wave of research is revealing that these medications may also help with a range of health issues, from lowering the risk of heart disease and certain cancers to treating sleep apnea and substance use disorders.
“These drugs are making a big difference because of how effective they are,” says Angela Godwin Beoku-Betts, a clinical assistant professor at the NYU Rory Meyers College of Nursing and board-certified family nurse practitioner who runs a private clinic in the Bronx focused on obesity...
Today's Sponsors
Today's Sponsor